Sign in

CIK 0001764013 · Large accelerated filer

Immunovant, Inc.

Sign in to watch
Ticker
IMVT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Mar 31
Incorporated
DE
Entity type
operating
EIN
832771572
Phone
917-410-3120
Business address
1000 PARK FORTY PLAZA, DURHAM, NC, 27713
Former names
Health Sciences Acquisitions Corp
  1. 4 Open-market sale Chief Financial Officer sold 10,000 shares at $38.46 ($384,600)
  2. 4 Planned sale Director sold 1,500 shares at $38.01 ($57,015)
  3. 4 Open-market sale Chief Legal Officer sold 2,634 shares at $35.39 ($93,217)
  4. 4 Planned sale Director sold 1,500 shares at $34.02 ($51,030)
  5. 4 Open-market sale Director sold 221,951 shares at an average $33.51 ($7,438,111)
  6. 4 Open-market sale Chief Operating Officer sold 3,115 shares at an average $32.45 ($101,072)
  7. 4 Planned sale Director sold 6,000 shares at $32.00 ($192,000)
  8. 4 Planned sale Director sold 2,502 shares at $27.17 ($67,979)
  9. 4 Open-market sale Chief Financial Officer sold 25,760 shares at $29.62 ($763,011)
  10. 4 Open-market sale Chief Technology Officer sold 2,754 shares at $29.62 ($81,573)
  11. 4 Open-market sale Chief Legal Officer sold 5,165 shares at $24.83 ($128,247)
  12. 4 Open-market sale Chief Operating Officer sold 8,722 shares at $24.83 ($216,567)
  13. 4 Open-market sale Chief Technology Officer sold 10,132 shares at $24.83 ($251,578)
  14. 4 Grant or award Director acquired 174,189 shares (grant or award)
  15. 4 Grant or award Director acquired 13,880 shares (grant or award)
  16. 4 Grant or award Director acquired 13,880 shares (grant or award)
  17. 4 Grant or award Director acquired 13,880 shares (grant or award)
  18. 4 Grant or award Director acquired 13,880 shares (grant or award)
  19. 4 Grant or award Director acquired 13,880 shares (grant or award)
  20. 4 Grant or award Chief Operating Officer acquired 83,671 shares (grant or award)

Page 2 of 18 · 360 filings